查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032953

豬隻保健市場規模、佔有率、趨勢和預測：按產品、疾病、給藥途徑、分銷管道和地區分類，2026-2034 年

Swine Healthcare Market Size, Share, Trends and Forecast by Product, Disease, Route of Administration, Distribution Channel, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2025年全球豬隻保健市場規模為34億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以5.91%的複合年成長率成長，到2034年達到57億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過38.0%。豬保健市場的成長主要得益於人們對豬肉產品依賴性的不斷提高、商業性養豬和出口活動的顯著增加，以及對豬源性疾病認知的不斷提高。

豬肉消費量的成長、動物健康意識的提高以及獸醫學的進步推動了豬保健市場的發展。因此，該市場涵蓋與豬病預防和治療相關的藥品、疫苗、飼料添加劑和診斷產品。主要市場促進因素包括豬病（如非洲豬瘟）的日益流行，導致疾病預防的投資增加。全球幾乎所有地區政府和監管機構實施的嚴格生物安全措施也推動了市場需求。精準農業和人工智慧診斷技術等技術進步也在革新豬保健領域。對抗生素抗藥性的日益關注促使人們增加對益生菌和草藥飼料添加劑等替代治療方法的研究。亞太地區和北美養豬業的成長推動了全球豬保健市場穩步擴張。各公司將專注於開發新產品和建立策略合作夥伴關係，以增強其市場地位。如今，人們越來越關注永續和抗病性強的牲畜，豬保健產業前景光明，並有望持續成長，同時確保提高生產力並妥善照顧動物。

受豬肉產量成長、疾病發生率上升以及獸醫學進步的推動，美國正崛起為豬保健領域的重要區域市場。此領域主要包括藥品、疫苗、飼料添加劑和診斷解決方案，旨在保障豬的健康和生產力。豬繁殖與呼吸綜合症（PRRS）和非洲食品藥物管理局（ASF）等疾病的存在是推動市場發展的關鍵因素，這些疾病需要增加對生物安全和預防醫學的投資。此外，美國食品藥物管理局（FDA）對抗生素使用的更嚴格監管也促使人們對益生菌和精準營養等替代解決方案的需求增加。人工智慧驅動的診斷和精密農業技術正在進一步變革豬保健領域。市場領導企業正加大研發投入並建立策略夥伴關係，以增強產品系列。美國是全球豬肉生產大國。憑藉疾病管理實踐、永續農業實踐和更完善的獸醫干預措施的創新，該市場有望持續成長。

豬保健市場的發展趨勢：

由於疾病蔓延，對豬保健的需求日益增加

與豬隻健康相關的疾病蔓延將推動市場需求。豬流感、沙門氏菌病、黴漿菌病和經典豬瘟（CSF）對牲畜和人類健康構成重大威脅。因此，人們對這些疾病的預防和控制意識不斷提高，導致對疫苗、抗生素和診斷設備的需求增加。政府計畫也透過豬病控制和管理推動市場成長，其中補貼和研究經費是支持疾病控制的關鍵組成部分。影像學和臨床檢測技術的進步使得感染疾病的早期治療和控制成為可能，從而減少了養豬戶的損失。根據美國國家生物技術資訊中心（NCBI）的數據顯示，自1960年代以來，全球生豬產量增加了140%，凸顯了採取強力的醫療保健措施以確保養豬業永續性的必要性。人們對通用感染疾病的日益關注正在推動研發工作，以提高疫苗的有效性，並培育出更具抵抗力和無病性的豬群。

商業養豬業和豬肉消費的擴張

在國際市場對豬肉需求持續成長的推動下，商業養豬業的快速擴張對豬保健的需求起到了至關重要的作用。這與養豬場不斷投資並利用豬群保健服務以提高和最佳化生產力密切相關。報告顯示，2024年豬肉消費量為11.26萬噸，預計2031年將增加至12.9萬噸。然而，其主要目標是疾病預防和畜群管理。隨著養豬場的整合，疫苗接種、消毒規程和營養補充劑等生物安全措施對於預防疾病爆發和確保永續生產至關重要。此外，養豬業的出口導向特點，對高品質、無病豬肉的需求，正在推動透過基因改造和精準農業等先進獸醫技術的應用。在大多數出口國，動物福利和疾病管制都受到嚴格監管。由於豬肉是世界上消費量最大的蛋白質來源之一，隨著養豬業的發展，對綜合性豬保健解決方案的需求也將不斷成長。

豬獸醫技術和疾病管理的進展

獸醫保健技術的進步正在塑造生豬保健市場的發展趨勢，為疾病預防、診斷和治療提供了更有效的手段。動物醫院中影像學和臨床檢測技術的日益普及，推動了對診斷工具及相關設備的需求，這些工具和設備可用於疾病的早期發現和管理。精準醫療、人工智慧監控系統和自動化餵食解決方案等創新技術正在改善牲畜的健康和生產力。豬流感和豬隻流行性腹瀉（CSF）疫苗的研發工作正在如火如荼地進行，旨在開發更有效的預防措施，從而減少疾病感染和經濟損失。遠端醫療的引入促進了數據驅動型畜牧業的發展，使養殖戶能夠在畜牧管理中做出更有利於動物健康和福利的決策。有機和無抗生素豬肉的生產正在推動益生菌和草藥療法等替代保健解決方案的創新。隨著全球化以前所未有的速度加速疾病向新地區的傳播，各國政府和產業領導者正在投資最新的獸醫技術，以確保食品安全、維護動物福利標準並維持生豬養殖業的永續發展。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球豬保健市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 診斷測試
    • 主要部分
      • 酵素免疫分析法（ELISA）
      • 快速免疫動員（RIM）
      • 瓊脂凝膠免疫擴散法（AGID）
      • 聚合酵素鏈鎖反應（PCR）
      • 診斷影像
      • 其他
  • 治療
    • 主要部分
      • 疫苗
      • 殺蟲劑
      • 抗感染藥物
      • 飼料添加劑
      • 其他

第7章 市場區隔：依疾病分類

  • 滲出性皮膚炎
  • 球蟲
  • 呼吸系統疾病
  • 豬痢疾
  • 豬細小病毒
  • 其他

第8章 市場區隔：依給藥途徑

  • 注射藥物
  • 口服

第9章 市場區隔：依分銷通路分類

  • 動物醫院
  • 零售藥房
  • 網路藥房

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章：促進、抑制與機遇

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Boehringer Ingelheim International GmbH
    • Ceva Animal Health Inc.
    • Elanco
    • IDEXX Laboratories Inc.
    • Innovative Diagnostic
    • Merck & Co. Inc.
    • Phibro Animal Health Corporation
    • Vetoquinol
    • Virbac Corporation
    • Zoetis Inc.
Product Code: SR112026A6654

The global swine healthcare market size was valued at USD 3.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 5.7 Billion by 2034, exhibiting a CAGR of 5.91% from 2026-2034. North America currently dominates the market, holding a market share of over 38.0% in 2025. The swine healthcare market share is growing due to the increasing dependence on swine products, a significant increase in commercial swine farming and export activities, and growing awareness regarding pork-transmitted diseases.

The swine healthcare market growth is attributed to the increasing pork consumption, growing awareness about animal health, and veterinary medicine advancements. Thus, the market encompasses pharmaceuticals, vaccines, feed additives, and diagnostic products relating to the prevention and treatment of diseases in pigs. The major drivers involve the rising prevalence of swine diseases like African swine fever, among others, and thus more investment toward preventing these diseases. The imposition of stringent biosecurity measures by governments and regulatory bodies in almost every corner of the globe is driving demand for the market. Advances in technology, like precision livestock farming and AI-based diagnostics, are also revolutionizing swine health care. Growing concerns about antibiotic resistance have sparked more research on alternative treatments such as probiotics and herbal feed additives. The global market for swine healthcare is expanding steadily, influenced by the increased pig farming activities in Asia-Pacific and North America. Companies will focus on new product development and strategic partnerships to make their presence better in the markets. Sustainable and disease-resistant livestock are receiving more attention today, and so the swine healthcare industry has a bright scope for continuous growth, ensuring more productivity and proper care of the animals.

The United States has emerged as a key regional market for swine healthcare, driven by increasing pork production, increased cases of disease outbreaks, and improved veterinary health care. The sector mainly comprises pharmaceuticals, vaccines, feed additives, and diagnostic solutions to ensure pig health and productivity. The major push factors are the presence of diseases such as PRRS and ASF, which require more investment in biosecurity and preventive healthcare. In addition, stricter regulations by the FDA on the use of antibiotics are accelerating the need for alternative solutions such as probiotics and precision nutrition. AI-based diagnostics and precision farming technologies are further changing the face of swine healthcare. The market leaders are making investments in R&D and strategic partnerships to make their product portfolios more robust. The U.S. is a global leader in pork production. In addition to innovation in the disease management practice, sustainable farm practice, and better veterinary intervention, the market will continue growing.

SWINE HEALTHCARE MARKET TRENDS:

Rising demand for swine healthcare due to disease prevalence

The increasing prevalence of diseases related to swine health will drive demand in the market. Swine flu, salmonella, mycoplasma hyopneumoniae, and classical swine fever (CSF) have become significant hazards to both livestock and human health conditions. Consequently, awareness about preventing and controlling these diseases has led to an increasing demand for vaccines, antibiotics, and diagnostic equipment. Government programs have also promoted market growth through swine disease control and management; subsidies and research funding are some of the key elements that help control the diseases. Diagnostic imaging and laboratory testing have also been improved, which has led to early treatment and control of infections so that fewer losses are incurred to swine farmers. As per the National Center for Biotechnology Information, the rising global pig production by 140% since the 1960s and necessity have therefore increased the need for strong healthcare measures to ensure the sustainability of the pork industry. Due to zoonotic diseases' rising concerns, R&D efforts continue to improve vaccine efficacy and pave a path to more resilient and disease-free swine.

Growing commercial pig farming and pork consumption

In rapid expansion, commercial pig farming has a significant role in boosting the swine healthcare demand, driven by the ongoing rising demand for pork in the international market, which continues to go with the farm that invests and seeks health services for herds to boost and optimize its production. According to the reports the consumption rate of pork standing at 112.6 Kilotons in 2024, it is expected to rise to 129 kilotons by 2031, however, primarily with the aim of disease prevention and livestock management. With the intensification of pig farming operations, biosecurity measures such as vaccination, disinfection protocols, and nutritional supplements are paramount to preventing outbreaks and ensuring sustainable production. Further, the swine industry's export orientation, which demands superior, disease-free pork, encourages the adoption of sophisticated veterinary care through genetic enhancement and precision livestock farming. Animal welfare and disease control measures have been very strict in most countries involved in exporting. As pork is one of the most consumed protein sources globally, there will be an increasing need for holistic swine healthcare solutions in line with industry growth.

Advancements in veterinary technology and swine disease management

Veterinary healthcare technological advancement is shaping the swine healthcare market trends by providing better means of disease prevention, diagnosis, and treatment. The increasing implementation of diagnostic imaging and laboratory testing in veterinary hospitals is driving the need for diagnostic tools and related items, which may be used in early disease detection and, consequently, its management. Innovations such as precision medicine, AI-driven monitoring systems, and automated feeding solutions boost livestock health and productivity. Extensive R&D has been conducted on the vaccine development phase of swine flu and CSF, which has brought more effective forms of immunization, thereby lessening the attacks and economic losses due to disease. Telemedicine increased data-driven animal farming, and livestock management has also allowed farmers to make better-informed decisions concerning animal health and welfare. Organic and antibiotic-free pork production is creating innovation in alternative healthcare solutions, such as probiotics and herbal remedies. As globalization pushes diseases into new regions more quickly than ever before, governments and industry leaders are investing in the latest veterinary technology to protect food, preserve animal welfare standards, and maintain swine growth.

SWINE HEALTHCARE INDUSTRY SEGMENTATION:

Analysis by Product:

  • Diagnostic Tests
    • Enzyme Linked Immuno-Sorbent Assay (ELISA)
    • Rapid Immuno Migration (RIM)
    • Agar Gel Immuno-Diffusion (AGID)
    • Polymerase Chain Reaction (PCR)
    • Diagnostic Imaging
    • Others
  • Therapeutics
    • Vaccines
    • Parasiticides
    • Anti-infectives
    • Feed Additives
    • Others

Therapeutics is the largest segment due to the prevalence of swine disease and increased utilization of veterinary pharmaceuticals in animal healthcare. Antibiotics, antiparasitics, and anti-inflammatory drugs are also employed extensively to prevent and control bacterial infections, parasites, and inflammatory diseases in pigs, which in return directly enhances the health and productivity of a herd. Alternative therapeutics such as phytogenic additives, probiotics, and immunostimulants, which have seen increased popularity in the market due to increasing concern over AMR, also fuel the shift in the trend of innovative therapeutics that build immunity and strengthen overall swine health. Growing investment in precision livestock farming and AI-driven drug development is driving growth in the market. Major players are working on developing targeted therapeutics with minimal side effects to improve the efficacy of treatment.

Analysis by Disease:

  • Exudative Dermatitis
  • Coccidiosis
  • Respiratory Diseases
  • Swine Dysentery
  • Porcine Parvovirus

Respiratory diseases account for the largest share. Mycoplasma pneumonia, swine influenza, pig reproductive and respiratory syndrome (PRRS), and other respiratory illnesses significantly affect swine production by causing reduced growth rates, increased mortality, and higher treatment costs. The broad prevalence of PRRS and the impact of this economically important disease have prompted a massive need for appropriate vaccines, antibiotics, and antiviral medicines. The shift of focus in preventing early-stage detection has raised interest in incorporating the latest available diagnostic tools in conjunction with various forms of farm-level biosecurity practices. Additionally, climate variations and increasing swine farm densities have contributed to the rapid spread of airborne respiratory pathogens, further escalating the demand for disease management solutions. The rising emphasis on precision medicine and targeted treatments has led to the development of next-generation vaccines and therapeutic strategies to combat respiratory illnesses.

Analysis by Route of Administration:

  • Injectable
  • Oral

Injectables represent a significant market due to their high efficacy, rapid absorption, and precise dosage delivery. Several vaccines, antibiotics, and anti-inflammatory drugs are administered through injection to initiate rapid therapeutic action. This is primarily seen with the operation of large-scale pig farming, where outbreaks of the diseases have to be contained speedily. Injectable solutions are also used with critical diseases like PRRS and African swine fever (ASF). Oral medications, comprising medicated feed additives, tablets, and liquid formulations, have been used frequently for long-term disease management and preventive care. Oral administration has the advantage of being less cumbersome, especially when dealing with larger herds. It minimizes stress and labor costs associated with handling pigs to administer injections. Feed-grade antibiotics, probiotics, and nutritional supplements are critical to maintaining gut health, building immunities, and preventing bacterial infections. The rise in antimicrobial resistance has compelled the market further toward natural and probiotic oral solutions. Although injectables still account for the largest portion of oral animal health products due to their efficacy, oral is fast emerging as an alternative as feed technology advances and other therapeutics such as antimicrobials and vaccines become more readily available.

Analysis by Distribution Channel:

  • Veterinary Hospitals
  • Retail Pharmacy
  • Online Pharmacy

Growth in demand for professional consultation, high-end diagnostic services, and advanced treatment is boosting the veterinary hospital market. For swine producers, veterinary hospitals provide specialized care, disease diagnosis, and access to prescription-based treatments, hence higher survival rates and farm productivity. Retail pharmacy is an important access point for easy availability of OTC veterinary medicines, feed supplements, and preventive healthcare products. These pharmacies are targeting small- and medium-scale swine farmers who need routine medications without necessarily requiring veterinary supervision. The retail channels for antibiotics, vitamins, dewormers, and vaccines ensure that these products are distributed and available widely. Online pharmacies are growing in popularity as veterinary healthcare is increasingly digitalized, and home delivery is convenient. Market access has been improved through e-commerce platforms for prescription and non-prescription drugs, feed additives, and healthcare products. Online channels also offer competitive pricing, purchases in bulk, and a larger product portfolio. With increasing internet penetration and telemedicine adoption, online pharmacies will be expected to have a greater market share in the future.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America holds the largest market with a share of 38.0%. This mainly resulted in dominance within the region due to high pork production levels, advanced veterinary infrastructure, and stringent biosecurity regulations. The U.S. is one of the world's largest pork producers, which naturally invests huge resources in disease prevention, precision farming, and veterinary pharmaceuticals. Increasing cases of PRRS, ASF, and other infectious diseases have put pressure on stakeholders to adopt preventive healthcare measures, including vaccines, biosecurity programs, and improvements in farm management practices. The need for regulatory bodies like the FDA and USDA ensures monitoring of antibiotic use and strict adherence to high standards of animal health. In addition, major pharmaceutical firms and research institutions are based in the region which would further hasten the development of state-of-the-art swine healthcare products. Innovation through AI-driven diagnostics, monitoring of disease in real-time, and sustainable farming solutions further fuel market growth.

The animal healthcare market in Europe is driven by strict animal welfare regulations, modern veterinary infrastructure, and rising demand for antibiotic-free pork. The top pork producers include Germany, Spain, and Denmark, which invest heavily in biosecurity measures and strategies to prevent diseases. The growing concern of African Swine Fever (ASF) has stimulated vaccine development and early disease detection technologies. The EU ban on antibiotic growth promoters has spurred the use of probiotics, phytogenic additives, and precision nutrition solutions, which focus on sustainability.

Asia-Pacific is the global leader in pork production, and the major producers are China, Vietnam, and India. Fast industrial pig farming expansion has created a high risk of disease and increased the need for vaccines, diagnostics, and biosecurity solutions. ASF and PRRS outbreaks have resulted in increased investments in early detection technologies and genetic improvements. Increased consumer demand for safe, quality pork products has also led to governments tightening the use of antibiotics, thereby driving the market for natural feed additives and alternative therapeutics.

Latin America, which is dominated by Brazil, Mexico, and Argentina, is seeing a significant rise in swine production and exports, thus making the need for better disease management solutions imperative. Swine respiratory diseases and parasitic infections are recurrent, leading to a huge demand for vaccines, parasiticides, and PCR-based diagnostics. Governments are expanding vaccination programs and promoting biosecurity protocols to protect the industry. The rising export market to Asia and Europe has increased the focus on quality standards and disease-free certification, pushing investments in advanced veterinary services and precision livestock farming.

The Middle East & Africa swine healthcare market is relatively small however, as pig farming has been increasing lately in South Africa and parts of North Africa. The region continues to face such challenges as poor access to veterinary services, bad disease surveillance, and low uptake of modern health solutions. Increasing investments in livestock infrastructure and biosecurity programs improve the control of diseases. As the region focuses on improving food security and lowering its dependence on pork imports, the demand for cost-effective vaccines, diagnostic tests, and alternative feed solutions rises.

KEY REGIONAL TAKEAWAYS:

UNITED STATES SWINE HEALTHCARE MARKET ANALYSIS

In 2025, the United States held a share of 85.70% of the swine healthcare market in North America due to growing reliance on pork products. USDA indicates that US pork production will be expected at 12.8 Million Tons in 2024, hence marking a growth of 3.1% above 2023. Since pork remains the main protein, its usage and demand are up, raising its health demand from swine. The more people consume pork, the more demand to keep up their health requires healthy swine that are given quality healthcare through solutions. This is particularly critical in large-scale commercial farming operations where maintaining optimal swine health is essential for economic stability. As pork prices rise in line with the growing demand, farmers and industry stakeholders are increasingly investing in health management practices for swine to mitigate diseases, ensure high-quality meat production, and enhance overall productivity. Besides that, improvements in swine healthcare technologies and practices, combined with better veterinary care, have also spurred more acceptance. Healthier animals are the key to keeping and increasing pork production to respond to the increasingly large market demands.

EUROPE SWINE HEALTHCARE MARKET ANALYSIS

In Europe, increased swine healthcare adoption is strongly influenced by increasing awareness about pork-transmitted diseases. For example, the Member States reported 1929 outbreaks of ASF in 2023. That was five times more than reports from 2022. This is particularly due to the spread and outbreak of ASF in Croatia, which reported 1124 outbreaks, or 58% of total EU outbreaks. Due to the health risks posed by the consumption of infected pork products, regulations have become stricter, and the importance of maintaining optimal swine health has increased. These diseases, such as zoonotic pathogens, can have serious impacts on the health of the animals and on public health. There is a growing demand for safe, disease-free pork as consumer awareness increases, thus driving the need for advanced healthcare management for swine. Awareness has also brought about government and private sector initiatives focused on health standards in the swine industry. Farmers and vets are more interested in investing their time and effort in preventive measures, vaccination programs, and sound disease control techniques to minimize disease transmission risks. Stakeholders with such proactive considerations address the matter of both the welfare of the animals and public health safety, therefore ensuring a more reliable and safer pork supply.

ASIA PACIFIC SWINE HEALTHCARE MARKET ANALYSIS

The swine healthcare uptake in the Asia-Pacific region is driven by the increasing growth of online pharmacy services. For example, Walmart-owned Flipkart has also ventured into the e-pharmacy space that boasts more than 50 platforms offering services to nearly 22,000 pin codes across the country. Increasing internet penetration and a shift toward digital platforms have made it easier for farmers and breeders to access veterinary medicines and healthcare solutions. This growth in online pharmacy services has made it easier for stakeholders in the swine farming industry to access a wider range of swine healthcare products, including medications, vaccines, and supplements. The availability of these products online ensures timely interventions and better management of swine health, particularly in rural and remote areas. Moreover, the increasing number of local and international online platforms offering veterinary products has made the procurement process much easier, cost-effective, and accessible. The region is seeing a growing demand for pork; therefore, the adoption of swine healthcare is very important to enhance animal welfare, productivity, and overall supply chain efficiency, hence creating a healthier and more resilient industry.

LATIN AMERICA SWINE HEALTHCARE MARKET ANALYSIS

The increasing pork-eating population in Latin America is strongly related to the increasing disposable incomes and is directly connected to the total disposable income growth in Latin America, which is expected to be around 60% between 2021 and 2040. With people entering the middle class and experiencing greater financial security, the demand for meat products, such as pork, rises. This shift in dietary habits is coupled with a growing interest in the health and quality assurance of pork production. Swine health becomes an issue of importance as farmers want to continue supplying the increased demand while at the same time keeping up quality standards. Improving access to health care for swine would be necessary for the prevention of diseases, enhancing productivity, and improving animal welfare under intensified production efforts. The economic growth in the region is encouraging stakeholders to adopt better healthcare practices, which improve swine productivity and cater to consumer concerns about food safety and quality. This trend is boosting the overall development of the swine healthcare sector.

MIDDLE EAST AND AFRICA SWINE HEALTHCARE MARKET ANALYSIS

The adoption of swine healthcare in the Middle East and Africa is driven by the improving animal healthcare infrastructure. For example, in 2022 there will be approximately 1,200 licensed veterinarians across the UAE. Investments in veterinary services, research facilities, and healthcare training programs contribute to a more robust system for managing the health of swine populations. As agriculture develops and evolves, access to professional veterinary care, swine-specific healthcare solutions, and measures for disease prevention are becoming more widespread. This would have implications for small and medium-scale farmers, as improved healthcare also leads to increases in animal productivity and farm profitability. An enhanced animal healthcare infrastructure ensures better monitoring of animal health, more effective disease management, and improved biosecurity practices, all critical to the growth of the swine industry in the region.

COMPETITIVE LANDSCAPE:

Leading companies in the swine healthcare market are highly invested in product innovation, strategic partnerships, and geographic expansion to drive their market presence. One of the most significant trends is the adoption of precision livestock farming (PLF), where companies are integrating AI-driven disease detection, IoT-based monitoring, and real-time health analytics to enhance disease management. Another trend is the use of mRNA and recombinant vaccines, which have proven to be more effective in immunizing against viral infections such as PRRS and African Swine Fever (ASF). The regulatory reforms that limit the use of antibiotics are boosting the demand for probiotics, phytogenic feed additives, and immunostimulants as alternative solutions. Mergers and acquisitions also shape the industry, as companies expand their portfolios to include biologics, gene-editing technologies, and rapid diagnostic solutions. The focus on biosecurity, sustainability, and disease outbreaks intensifies, innovation efforts among market players will create a positive swine healthcare market outlook.

The report provides a comprehensive analysis of the competitive landscape in the swine healthcare market with detailed profiles of all major companies, including:

  • Boehringer Ingelheim International GmbH
  • Ceva Animal Health Inc.
  • Elanco
  • IDEXX Laboratories Inc.
  • Innovative Diagnostic
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Vetoquinol
  • Virbac Corporation
  • Zoetis Inc.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Swine Healthcare Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Diagnostic Tests
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)
      • 6.1.2.2 Rapid Immuno Migration (RIM)
      • 6.1.2.3 Agar Gel Immuno-Diffusion (AGID)
      • 6.1.2.4 Polymerase Chain Reaction (PCR)
      • 6.1.2.5 Diagnostic Imaging
      • 6.1.2.6 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Vaccines
      • 6.2.2.2 Parasiticides
      • 6.2.2.3 Anti-infectives
      • 6.2.2.4 Feed Additives
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Disease

  • 7.1 Exudative Dermatitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Coccidiosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Respiratory Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Swine Dysentery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Porcine Parvovirus
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Animal Health Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 IDEXX Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Innovative Diagnostic
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Phibro Animal Health Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Vetoquinol
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Virbac Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Zoetis Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Swine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Swine Healthcare Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Swine Healthcare Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Swine Healthcare Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Swine Healthcare Market: Breakup by Disease (in %), 2025
  • Figure 6: Global: Swine Healthcare Market: Breakup by Route of Administration (in %), 2025
  • Figure 7: Global: Swine Healthcare Market: Breakup by Distribution Channel (in %), 2025
  • Figure 8: Global: Swine Healthcare Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Swine Healthcare (Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Swine Healthcare (Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Swine Healthcare (Therapeutics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Swine Healthcare (Therapeutics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Swine Healthcare (Exudative Dermatitis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Swine Healthcare (Exudative Dermatitis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Swine Healthcare (Coccidiosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Swine Healthcare (Coccidiosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Swine Healthcare (Respiratory Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Swine Healthcare (Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Swine Healthcare (Swine Dysentery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Swine Healthcare (Swine Dysentery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Swine Healthcare (Porcine Parvovirus) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Swine Healthcare (Porcine Parvovirus) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Swine Healthcare (Other Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Swine Healthcare (Other Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Swine Healthcare (Injectable) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Swine Healthcare (Injectable) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Swine Healthcare (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Swine Healthcare (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Swine Healthcare (Veterinary Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Swine Healthcare (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Swine Healthcare (Retail Pharmacy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Swine Healthcare (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Swine Healthcare (Online Pharmacy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Swine Healthcare (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: North America: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: North America: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: United States: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: United States: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Canada: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Canada: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Asia-Pacific: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Asia-Pacific: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: China: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: China: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Japan: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Japan: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: India: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: India: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: South Korea: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: South Korea: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Australia: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Australia: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Indonesia: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Indonesia: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Others: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Others: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Europe: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Europe: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Germany: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Germany: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: France: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: France: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: United Kingdom: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: United Kingdom: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Italy: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Italy: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Spain: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Spain: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Russia: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Russia: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Latin America: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Latin America: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Brazil: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Brazil: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Mexico: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Mexico: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Others: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Others: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Middle East and Africa: Swine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Middle East and Africa: Swine Healthcare Market: Breakup by Country (in %), 2025
  • Figure 83: Middle East and Africa: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Global: Swine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Swine Healthcare Industry: Value Chain Analysis
  • Figure 86: Global: Swine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Swine Healthcare Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Swine Healthcare Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Swine Healthcare Market Forecast: Breakup by Disease (in Million USD), 2026-2034
  • Table 4: Global: Swine Healthcare Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 5: Global: Swine Healthcare Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 6: Global: Swine Healthcare Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Swine Healthcare Market: Competitive Structure
  • Table 8: Global: Swine Healthcare Market: Key Players